Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (41-50 of 775) with videos related to

Pageof 78
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2024
Biomarkers for Personalizing IBD Therapy: The Quest ContinuesRaja Atreya, Markus F Neurath
Cells|July 14, 2023
Novel Small Molecules in IBD: Current State and Future PerspectivesAndré Jefremow, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|November 16, 2025
Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitisRaja Atreya, Markus F Neurath
United European Gastroenterology Journal|January 31, 2025
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic ResponseRaja Atreya, Markus F Neurath
Current Opinion in Gastroenterology|April 27, 2016
From bench to bedside: molecular imaging in inflammatory bowel diseasesRaja Atreya, Markus F Neurath
Immunity|February 21, 2019
A Dual Role for TNF-Producing T Cells in the Fetal IntestineMoritz Leppkes, Markus F Neurath
Current Opinion in Gastroenterology|February 11, 2005
Mucosal T cells: mediators or guardians of inflammatory bowel disease?Jonas Mudter, Markus F Neurath
Clinical Reviews in Allergy & Immunology|September 1, 2005
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancerRaja Atreya, Markus F Neurath
Expert Review of Anticancer Therapy|April 12, 2008
Immune cells in colorectal cancer: prognostic relevance and therapeutic strategiesImke Atreya, Markus F Neurath
Inflammatory Bowel Diseases|October 14, 2003
The role of signal transducers and activators of transcription in T inflammatory bowel diseasesJonas Mudter, Markus F Neurath
Pageof 78

Showing results (41-50 of 775) with videos related to

Sort By:
Pageof 78
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2024
Biomarkers for Personalizing IBD Therapy: The Quest ContinuesRaja Atreya, Markus F Neurath
Cells|July 14, 2023
Novel Small Molecules in IBD: Current State and Future PerspectivesAndré Jefremow, Markus F Neurath
The Lancet. Gastroenterology & Hepatology|November 16, 2025
Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitisRaja Atreya, Markus F Neurath
United European Gastroenterology Journal|January 31, 2025
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic ResponseRaja Atreya, Markus F Neurath
Current Opinion in Gastroenterology|April 27, 2016
From bench to bedside: molecular imaging in inflammatory bowel diseasesRaja Atreya, Markus F Neurath
Immunity|February 21, 2019
A Dual Role for TNF-Producing T Cells in the Fetal IntestineMoritz Leppkes, Markus F Neurath
Current Opinion in Gastroenterology|February 11, 2005
Mucosal T cells: mediators or guardians of inflammatory bowel disease?Jonas Mudter, Markus F Neurath
Clinical Reviews in Allergy & Immunology|September 1, 2005
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancerRaja Atreya, Markus F Neurath
Expert Review of Anticancer Therapy|April 12, 2008
Immune cells in colorectal cancer: prognostic relevance and therapeutic strategiesImke Atreya, Markus F Neurath
Inflammatory Bowel Diseases|October 14, 2003
The role of signal transducers and activators of transcription in T inflammatory bowel diseasesJonas Mudter, Markus F Neurath
Pageof 78